Mirae Asset Global Etfs Holdings Ltd. Edgewise Therapeutics, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.4 Billion
- Q1 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 43,776 shares of EWTX stock, worth $636,940. This represents 0.0% of its overall portfolio holdings.
Number of Shares
43,776
Previous 41,313
5.96%
Holding current value
$636,940
Previous $1.1 Million
12.69%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding EWTX
# of Institutions
222Shares Held
105MCall Options Held
2.57MPut Options Held
1.58M-
Orbimed Advisors LLC San Diego, CA15MShares$219 Million10.3% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.91MShares$130 Million4.07% of portfolio
-
Perceptive Advisors LLC New York, NY6.55MShares$95.3 Million6.03% of portfolio
-
Baker Bros. Advisors LP New York, NY6.16MShares$89.6 Million1.61% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$87.5 Million0.0% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $919M
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...